☰

Daniel E. Frigo, Ph.D. - Publications

Affiliations: 
2003 Tulane University, New Orleans, LA, United States 
Area:
Molecular Biology, Cell Biology, Toxicology
Tree Info Similar researchers PubMed Report error

47 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Hasterok S, Scott TG, Roller DG, Spencer A, Dutta AB, Sathyan KM, Frigo DE, Guertin MJ, Gioeli D. The androgen receptor does not directly regulate the transcription of DNA damage response genes. Molecular Cancer Research : McR. PMID 37698543 DOI: 10.1158/1541-7786.MCR-23-0358  0.325
2021 Frigo DE, Bondesson M, Williams C. Nuclear receptors: from molecular mechanisms to therapeutics. Essays in Biochemistry. 65: 847-856. PMID 34825698 DOI: 10.1042/EBC20210020  0.364
2021 Lin C, Blessing AM, Pulliam TL, Shi Y, Wilkenfeld SR, Han JJ, Murray MM, Pham AH, Duong K, Brun SN, Shaw RJ, Ittmann MM, Frigo DE. Inhibition of CAMKK2 impairs autophagy and castration-resistant prostate cancer via suppression of AMPK-ULK1 signaling. Oncogene. PMID 33531625 DOI: 10.1038/s41388-021-01658-z  0.391
2020 Chen R, Liang X, Murray MM, Karasik E, Han JJ, Zhu M, Foster BA, Frigo DE, Wang G. A simple quantitative PCR assay to determine TRAMP transgene zygosity. Prostate Cancer and Prostatic Diseases. PMID 32895469 DOI: 10.1038/S41391-020-00282-4  0.305
2019 Cao S, Liu R, Yang L, Ahn J, Chen J, Wang Z, Efstathiou E, Frigo DE, Zhu H, Wang W. Abstract 4692: Deconvolution reveals cell-type specific transcriptional effects across cancer types Cancer Research. DOI: 10.1158/1538-7445.Sabcs18-4692  0.345
2018 White MA, Frigo DE. Regulation of SLC1A4 and SLC1A5 in Prostate Cancer-Response. Molecular Cancer Research : McR. 16: 1811-1812. PMID 30385664 DOI: 10.1158/1541-7786.Mcr-18-0240  0.324
2018 Awad D, Pulliam TL, Lin C, Wilkenfeld SR, Frigo DE. Delineation of the androgen-regulated signaling pathways in prostate cancer facilitates the development of novel therapeutic approaches. Current Opinion in Pharmacology. 41: 1-11. PMID 29609138 DOI: 10.1016/J.Coph.2018.03.002  0.441
2018 Yu G, Cheng CJ, Lin SC, Lee YC, Frigo DE, Yu-Lee LY, Gallick GE, Titus MA, Nutt LK, Lin SH. Organelle-derived acetyl-CoA promotes prostate cancer cell survival, migration, and metastasis via activation of calmodulin kinase II. Cancer Research. PMID 29535221 DOI: 10.1158/0008-5472.Can-17-2392  0.345
2018 White MA, Tsouko E, Lin C, Rajapakshe K, Spencer JM, Wilkenfeld SR, Vakili SS, Pulliam TL, Awad D, Nikolos F, Katreddy RR, Kaipparettu BA, Sreekumar A, Zhang X, Cheung E, ... ... Frigo DE, et al. GLUT12 promotes prostate cancer cell growth and is regulated by androgens and CaMKK2 signaling. Endocrine-Related Cancer. PMID 29431615 DOI: 10.1530/Erc-17-0051  0.462
2017 Wilkenfeld SR, Lin C, Frigo DE. Communication between genomic and non-genomic signaling events coordinate steroid hormone actions. Steroids. PMID 29155216 DOI: 10.1016/J.Steroids.2017.11.005  0.396
2017 White MA, Lin C, Rajapakshe K, Dong J, Shi Y, Tsouko E, Mukhopadhyay R, Jasso D, Dawood W, Coarfa C, Frigo DE. Glutamine Transporters are Targets of Multiple Oncogenic Signaling Pathways in Prostate Cancer. Molecular Cancer Research : McR. PMID 28507054 DOI: 10.1158/1541-7786.Mcr-16-0480  0.465
2017 Khan AS, Frigo DE. A spatiotemporal hypothesis for the regulation, role, and targeting of AMPK in prostate cancer. Nature Reviews. Urology. PMID 28169991 DOI: 10.1038/Nrurol.2016.272  0.478
2017 Shatnawi AA, Malkaram SA, Tsouko E, Frigo DE. Abstract 3326: Identification of a novel androgen receptor co-regulator in prostate cancer Cancer Research. 77: 3326-3326. DOI: 10.1158/1538-7445.Am2017-3326  0.404
2016 Blessin AM, Rajapakshe K, Reddy Bollu L, Shi Y, White MA, Pham AH, Lin C, Jonsson P, Cortes CJ, Cheung E, La Spada AR, Bast RC, Merchant FA, Coarfa C, Frigo DE. Transcriptional Regulation of Core Autophagy and Lysosomal Genes by the Androgen Receptor Promotes Prostate Cancer Progression. Autophagy. 0. PMID 27977328 DOI: 10.1080/15548627.2016.1268300  0.424
2016 Kaushik AK, Shojaie A, Panzitt K, Sonavane R, Venghatakrishnan H, Manikkam M, Zaslavsky A, Putluri V, Vasu VT, Zhang Y, Khan AS, Lloyd S, Szafran AT, Dasgupta S, Bader DA, ... ... Frigo DE, et al. Inhibition of the hexosamine biosynthetic pathway promotes castration-resistant prostate cancer. Nature Communications. 7: 11612. PMID 27194471 DOI: 10.1038/Ncomms11612  0.482
2016 Park JH, Vithayathil S, Kumar S, Sung PL, Dobrolecki LE, Putluri V, Bhat VB, Bhowmik SK, Gupta V, Arora K, Wu D, Tsouko E, Zhang Y, Maity S, Donti TR, ... ... Frigo DE, et al. Fatty Acid Oxidation-Driven Src Links Mitochondrial Energy Reprogramming and Oncogenic Properties in Triple-Negative Breast Cancer. Cell Reports. PMID 26923594 DOI: 10.1016/J.Celrep.2016.02.004  0.405
2016 Klionsky DJ, Abdelmohsen K, Abe A, Abedin MJ, Abeliovich H, Acevedo Arozena A, Adachi H, Adams CM, Adams PD, Adeli K, Adhihetty PJ, Adler SG, Agam G, Agarwal R, Aghi MK, ... ... Frigo DE, et al. Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition). Autophagy. 12: 1-222. PMID 26799652 DOI: 10.1080/15548627.2015.1100356  0.32
2016 Park JH, Vithayathil S, Wu D, Putluri V, Sung P, Tsouko E, Bhat VB, Coarfa C, Frigo DE, Lewis MT, Sreekumar A, Yotnda P, Creighton CJ, Putluri N, Wong LC, et al. Abstract 217: Mitochondrial reprogramming regulated cancer pathway in triple negative breast cancer Cancer Research. 76: 217-217. DOI: 10.1158/1538-7445.Am2016-217  0.416
2016 Kaushik AK, Shojaie A, Panzitt K, Sonavane R, Venghatakrishnan H, Manikkam M, Zaslavsky A, Putluri V, Vasu V, Zhang Y, Khan A, Lloyd S, Szafran A, Dasgupta S, Bader D, ... ... Frigo D, et al. Abstract 1056: Inhibition of hexose monophosphate pathway promotes castration resistant prostate cancer Cancer Research. 76: 1056-1056. DOI: 10.1158/1538-7445.Am2016-1056  0.375
2015 Shafi AA, Putluri V, Arnold JM, Tsouko E, Maity S, Roberts JM, Coarfa C, Frigo DE, Putluri N, Sreekumar A, Weigel NL. Differential regulation of metabolic pathways by androgen receptor (AR) and its constitutively active splice variant, AR-V7, in prostate cancer cells. Oncotarget. PMID 26378018 DOI: 10.18632/Oncotarget.5585  0.416
2015 Blessing AM, Ganesan S, Rajapakshe K, Ying Sung Y, Reddy Bollu L, Shi Y, Cheung E, Coarfa C, Chang JT, McDonnell DP, Frigo DE. Identification of a Novel Coregulator, SH3YL1, That Interacts With the Androgen Receptor N-Terminus. Molecular Endocrinology (Baltimore, Md.). 29: 1426-39. PMID 26305679 DOI: 10.1210/Me.2015-1079  0.473
2015 Tsouko E, Wang J, Frigo DE, Aydogdu E, Williams C. miR-200a inhibits migration of triple-negative breast cancer cells through direct repression of the EPHA2 oncogene. Carcinogenesis. PMID 26088362 DOI: 10.1093/Carcin/Bgv087  0.361
2015 Popovics P, Frigo DE, Schally AV, Rick FG. Targeting the 5'-AMP-activated protein kinase and related metabolic pathways for the treatment of prostate cancer. Expert Opinion On Therapeutic Targets. 19: 617-32. PMID 25600663 DOI: 10.1517/14728222.2015.1005603  0.443
2015 Park JH, Kumar S, Vithayathil S, Arora K, Putluri N, Tsouko E, Donti TR, Frigo DE, Creighton CJ, Lewis MT, Sreekumar A, Wong L, Kaipparettu BA. Abstract P1-07-06: Activation of oncogenic pathways by mitochondrial reprogramming in triple negative breast cancer Cancer Research. 75. DOI: 10.1158/1538-7445.Sabcs14-P1-07-06  0.482
2015 Shi Y, Tsouko E, Blessing AM, Tennakoon J, Han JJ, Ittmann MM, Frigo DE. Abstract 1136: Regulation of AMPK by androgen receptor signaling and its role in promoting prostate cancer through the use of autophagy Cancer Research. 75: 1136-1136. DOI: 10.1158/1538-7445.Am2015-1136  0.492
2014 Tsouko E, Khan AS, White MA, Han JJ, Shi Y, Merchant FA, Sharpe MA, Xin L, Frigo DE. Regulation of the pentose phosphate pathway by an androgen receptor-mTOR-mediated mechanism and its role in prostate cancer cell growth. Oncogenesis. 3: e103. PMID 24861463 DOI: 10.1038/oncsis.2014.18  0.338
2014 Tennakoon JB, Shi Y, Han JJ, Tsouko E, White MA, Burns AR, Zhang A, Xia X, Ilkayeva OR, Xin L, Ittmann MM, Rick FG, Schally AV, Frigo DE. Androgens regulate prostate cancer cell growth via an AMPK-PGC-1α-mediated metabolic switch. Oncogene. 33: 5251-61. PMID 24186207 DOI: 10.1038/Onc.2013.463  0.445
2014 Frigo DE, Shi Y, Han JJ, Tsouko E, Ittmann MM. Abstract 2450: CaMKK2-AMPK signaling facilitates androgen-mediated prostate cancer cell metabolism Cancer Research. 74: 2450-2450. DOI: 10.1158/1538-7445.Am2014-2450  0.46
2013 Augello MA, Burd CJ, Birbe R, McNair C, Ertel A, Magee MS, Frigo DE, Wilder-Romans K, Shilkrut M, Han S, Jernigan DL, Dean JL, Fatatis A, McDonnell DP, Visakorpi T, et al. Convergence of oncogenic and hormone receptor pathways promotes metastatic phenotypes. The Journal of Clinical Investigation. 123: 493-508. PMID 23257359 DOI: 10.1172/Jci64750  0.478
2013 Shi Y, Han JJ, Tennakoon JB, Mehta FF, Merchant FA, Burns AR, Howe MK, McDonnell DP, Frigo DE. Androgens promote prostate cancer cell growth through induction of autophagy. Molecular Endocrinology (Baltimore, Md.). 27: 280-95. PMID 23250485 DOI: 10.1210/Me.2012-1260  0.395
2012 Collins-Burow BM, Antoon JW, Frigo DE, Elliott S, Weldon CB, Boue SM, Beckman BS, Curiel TJ, Alam J, McLachlan JA, Burow ME. Antiestrogenic activity of flavonoid phytochemicals mediated via the c-Jun N-terminal protein kinase pathway. Cell-type specific regulation of estrogen receptor alpha. The Journal of Steroid Biochemistry and Molecular Biology. 132: 186-93. PMID 22634477 DOI: 10.1016/J.Jsbmb.2012.05.004  0.699
2012 Bratton MR, Frigo DE, Segar HC, Nephew KP, McLachlan JA, Wiese TE, Burow ME. The organochlorine o,p'-DDT plays a role in coactivator-mediated MAPK crosstalk in MCF-7 breast cancer cells. Environmental Health Perspectives. 120: 1291-6. PMID 22609851 DOI: 10.1289/Ehp.1104296  0.609
2012 Bratton MR, Antoon JW, Duong BN, Frigo DE, Tilghman S, Collins-Burow BM, Elliott S, Tang Y, Melnik LI, Lai L, Alam J, Beckman BS, Hill SM, Rowan BG, McLachlan JA, et al. Gαo potentiates estrogen receptor α activity via the ERK signaling pathway. The Journal of Endocrinology. 214: 45-54. PMID 22562654 DOI: 10.1530/Joe-12-0097  0.728
2012 Augello MA, Burd C, Bribe R, Frigo D, Karch J, McDonnell D, Visakorpi T, Knudsen KE. Abstract A50: Cyclin D1 isoforms selectively manipulate AR signaling to promote metastatic phenotypes in early and castration-resistant prostate cancer. Cancer Research. 72: A50-A50. DOI: 10.1158/1538-7445.Prca2012-A50  0.38
2011 Frigo DE, Howe MK, Wittmann BM, Brunner AM, Cushman I, Wang Q, Brown M, Means AR, McDonnell DP. CaM kinase kinase beta-mediated activation of the growth regulatory kinase AMPK is required for androgen-dependent migration of prostate cancer cells. Cancer Research. 71: 528-37. PMID 21098087 DOI: 10.1158/0008-5472.Can-10-2581  0.478
2009 Frigo DE, Sherk AB, Wittmann BM, Norris JD, Wang Q, Joseph JD, Toner AP, Brown M, McDonnell DP. Induction of Kruppel-like factor 5 expression by androgens results in increased CXCR4-dependent migration of prostate cancer cells in vitro. Molecular Endocrinology (Baltimore, Md.). 23: 1385-96. PMID 19460858 DOI: 10.1210/Me.2009-0010  0.419
2009 Wardell SE, Ilkayeva OR, Wieman HL, Frigo DE, Rathmell JC, Newgard CB, McDonnell DP. Glucose metabolism as a target of histone deacetylase inhibitors. Molecular Endocrinology (Baltimore, Md.). 23: 388-401. PMID 19106193 DOI: 10.1210/Jcem.94.2.9997  0.329
2009 Bratton MR, Frigo DE, Vigh-Conrad KA, Fan D, Wadsworth S, McLachlan JA, Burow ME. Organochlorine-mediated potentiation of the general coactivator p300 through p38 mitogen-activated protein kinase. Carcinogenesis. 30: 106-13. PMID 18791200 DOI: 10.1093/Carcin/Bgn213  0.65
2008 Sherk AB, Frigo DE, Schnackenberg CG, Bray JD, Laping NJ, Trizna W, Hammond M, Patterson JR, Thompson SK, Kazmin D, Norris JD, McDonnell DP. Development of a small-molecule serum- and glucocorticoid-regulated kinase-1 antagonist and its evaluation as a prostate cancer therapeutic. Cancer Research. 68: 7475-83. PMID 18794135 DOI: 10.1158/0008-5472.Can-08-1047  0.429
2008 Frigo DE, McDonnell DP. Differential effects of prostate cancer therapeutics on neuroendocrine transdifferentiation. Molecular Cancer Therapeutics. 7: 659-69. PMID 18347151 DOI: 10.1158/1535-7163.Mct-07-0480  0.411
2006 Duong BN, Elliott S, Frigo DE, Melnik LI, Vanhoy L, Tomchuck S, Lebeau HP, David O, Beckman BS, Alam J, Bratton MR, McLachlan JA, Burow ME. AKT regulation of estrogen receptor beta transcriptional activity in breast cancer. Cancer Research. 66: 8373-81. PMID 16951146 DOI: 10.1158/0008-5472.Can-05-3845  0.724
2006 Frigo DE, Basu A, Nierth-Simpson EN, Weldon CB, Dugan CM, Elliott S, Collins-Burow BM, Salvo VA, Zhu Y, Melnik LI, Lopez GN, Kushner PJ, Curiel TJ, Rowan BG, McLachlan JA, et al. p38 mitogen-activated protein kinase stimulates estrogen-mediated transcription and proliferation through the phosphorylation and potentiation of the p160 coactivator glucocorticoid receptor-interacting protein 1. Molecular Endocrinology (Baltimore, Md.). 20: 971-83. PMID 16410316 DOI: 10.1210/Me.2004-0075  0.678
2005 Frigo DE, Vigh KA, Struckhoff AP, Elliott S, Beckman BS, Burow ME, McLachlan JA. Xenobiotic-induced TNF-alpha expression and apoptosis through the p38 MAPK signaling pathway. Toxicology Letters. 155: 227-38. PMID 15603917 DOI: 10.1016/J.Toxlet.2004.09.008  0.648
2004 Weldon CB, Parker AP, Patten D, Elliott S, Tang Y, Frigo DE, Dugan CM, Coakley EL, Butler NN, Clayton JL, Alam J, Curiel TJ, Beckman BS, Jaffe BM, Burow ME. Sensitization of apoptotically-resistant breast carcinoma cells to TNF and TRAIL by inhibition of p38 mitogen-activated protein kinase signaling. International Journal of Oncology. 24: 1473-80. PMID 15138590 DOI: 10.3892/Ijo.24.6.1473  0.499
2004 Frigo DE, Tang Y, Beckman BS, Scandurro AB, Alam J, Burow ME, McLachlan JA. Mechanism of AP-1-mediated gene expression by select organochlorines through the p38 MAPK pathway. Carcinogenesis. 25: 249-61. PMID 14604893 DOI: 10.1093/Carcin/Bgh009  0.672
2002 Frigo DE, Burow ME, Mitchell KA, Chiang TC, McLachlan JA. DDT and its metabolites alter gene expression in human uterine cell lines through estrogen receptor-independent mechanisms. Environmental Health Perspectives. 110: 1239-45. PMID 12460804 DOI: 10.1289/Ehp.021101239  0.729
2002 Frigo DE, Duong BN, Melnik LI, Schief LS, Collins-Burow BM, Pace DK, McLachlan JA, Burow ME. Flavonoid phytochemicals regulate activator protein-1 signal transduction pathways in endometrial and kidney stable cell lines. The Journal of Nutrition. 132: 1848-53. PMID 12097658 DOI: 10.1093/Jn/132.7.1848  0.736
Show low-probability matches.